MMSINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
MERIT MEDICAL SYSTEMS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$89.96+0.76 (+0.85%)
Close on Oct 19, 2026
- Market cap
- $5.40B
- P/E (TTM)
- 37.2
- Dividend yield
- –
Share price
+$8.10 (+9.89%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
MERIT MEDICAL SYSTEMS INC grew revenue 10.2% to $1.58B over the twelve months to Jun 30, 2026. Operating income rose 24.5% to $201.37M, moving the operating margin from 11.3% to 12.8%. Free cash flow was $203.21M, up 5.7% from a year earlier.
Revenue
$1.58B
+10.2% vs. a year earlier
Operating income
$201.37M
+24.5% vs. a year earlier
Free cash flow
$203.21M
+5.7% vs. a year earlier
EPS, diluted
$2.42
+22.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $5.40B
- P/E ratio
- 37.2
- Price to sales
- 3.42
- Price to book
- 3.21
- Dividend yield
- –
- Free cash flow yield
- 3.76%
Fundamentals
- Revenue
- $1.58B
- Net income
- $145.56M
- EPS, diluted
- $2.42
- Free cash flow
- $203.21M
- Book value per share
- $27.99
- Diluted shares
- 60M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$1.58B+10.2% YoY
Gross profit
$781.73M+13.8% YoY
Operating income
$201.37M+24.5% YoY
Net income
$145.56M+22.2% YoY
EPS, diluted
$2.42+22.8% YoY
Free cash flow
$203.21M+5.7% YoY
Reported periodTrailing twelve months